Lilly weight-loss pill orforglipron could get FDA approval in 2026, CEO Dave Ricks says
Eli Lilly & Co., the Fortune 500 pharma firm that manufactures weight-loss injection Zepbound (tirzepatide), has a comparable…
Browsing Tag